Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Anna, Sundlöv"'
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-16 (2023)
Abstract Background Segmenting the whole-body somatostatin receptor-expressing tumour volume (SRETVwb) on positron emission tomography/computed tomography (PET/CT) images is highly time-consuming but has shown value as an independent prognostic facto
Externí odkaz:
https://doaj.org/article/0d76d4f30aa84135b773179e42e9b9c7
Autor:
Anna Stenvall, Johan Gustafsson, Erik Larsson, Daniel Roth, Anna Sundlöv, Lena Jönsson, Cecilia Hindorf, Tomas Ohlsson, Katarina Sjögreen Gleisner
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Background Somatostatin receptor 68Ga PET imaging is standard for evaluation of a patient’s suitability for 177Lu peptide receptor radionuclide therapy of neuroendocrine tumours (NETs). The 68Ga PET serves to ensure sufficient somatostatin
Externí odkaz:
https://doaj.org/article/461c307cac5b4fe5b9908f775fc1fa1d
Publikováno v:
EJNMMI Physics, Vol 7, Iss 1, Pp 1-22 (2020)
Abstract Background Currently, hand-held gamma cameras are being developed for 99mTc imaging, mainly for sentinel lymph node detection. These cameras offer advantages, such as mobility and ease of access, and may be useful also for other applications
Externí odkaz:
https://doaj.org/article/7b5ff1a36f414f7090d61a3b64d039ca
Autor:
Gitte Dam, Henning Grønbæk, Anna Sundlöv, Johan Botling, Anders Sundin, Rene Horsleben Petersen, Staffan Welin, Espen-Thiis Evensen, Halfdan Sorbye, Elizaveta Tabaksblat, Anne Kirstine Arveschoug, Jann Mortensen, Andreas Kjaer, Ulrich Knigge, Eva Tiensuu Janson, Seppo W. Langer
Publikováno v:
Acta Oncologica. :1-7
Autor:
Anna Sundlöv, Johan Gustafsson, Gustav Brolin, Nadja Mortensen, Rebecca Hermann, Peter Bernhardt, Johanna Svensson, Michael Ljungberg, Jan Tennvall, Katarina Sjögreen Gleisner
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-19 (2018)
Abstract Background Recently, 177Lu-dotatate therapy for neuroendocrine tumours has received regulatory approval. Dosimetry can be used to optimize treatment on an individual basis, but there is no international consensus as to how it should be done.
Externí odkaz:
https://doaj.org/article/7b809ad9da7e48b0b173b59638535498
Autor:
Anna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall, Michael Ljungberg, Carl Fredrik Warfvinge, Kajsa Holgersson, Andreas Hallqvist, Peter Bernhardt, Johanna Svensson
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:3830-3840
Purpose Radionuclide therapy with 177Lu-DOTATATE is well established for patients with advanced somatostatin receptor–positive neuroendocrine tumors with a standard schedule of 7.4 GBq at four occasions. However, this approach does not consider ind
Autor:
Stian Knappskog, Tobias Grob, Andreas Venizelos, Ursula Amstutz, Geir O. Hjortland, Inger M. Lothe, Christian Kersten, Eva Hofsli, Anna Sundlöv, Hege Elvebakken, Herish Garresori, Anne Couvelard, Johanna Svensson, Halfdan Sorbye, Aurel Perren
Publikováno v:
Knappskog, Stian; Grob, Tobias; Venizelos, Andreas; Amstutz, Ursula; Hjortland, Geir O; Lothe, Inger M; Kersten, Christian; Hofsli, Eva; Sundlöv, Anna; Elvebakken, Hege; Garresori, Herish; Couvelard, Anne; Svensson, Johanna; Sorbye, Halfdan; Perren, Aurel (2023). Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO precision oncology, 7, e2200336. American Society of Clinical Oncology 10.1200/PO.22.00336
PURPOSE Gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC) are rare and have a poor prognosis. Most GEP-NEC are diagnosed with metastatic disease, with only minor biopsies available for molecular diagnostics. We assessed the applicability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1970b14db7dc3567d76b6a5ce9d869f
Autor:
Hege Elvebakken, Sönke Detlefsen, Oleksii Nikolaienko, Aurel Perren, Stian Knappskog, Inger Marie Bowitz Lothe, Anna Sundlöv, Johanna Svensson, Anne Couvelard, Wei Deng, Harrish Garresori, Andreas Venizelos, Halfdan Sorbye, Merete Krogh, Christian Kersten, Geir Olav Hjortland, Eva Hofsli
Publikováno v:
Venizelos, Andreas; Elvebakken, Hege; Perren, Aurel; Nikolaienko, Oleksii; Deng, Wei; Lothe, Inger Marie B; Couvelard, Anne; Hjortland, Geir Olav; Sundlöv, Anna; Svensson, Johanna; Garresori, Harrish; Kersten, Christian; Hofsli, Eva; Detlefsen, Sönke; Krogh, Merete; Sorbye, Halfdan; Knappskog, Stian (2021). The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer, 29(1), pp. 1-14. BioScientifica Ltd. 10.1530/ERC-21-0152
Endocrine-Related Cancer
Venizelos, A, Elvebakken, H, Perren, A, Nikolaienko, O, Deng, W, Lothe, I M B, Couvelard, A, Hjortland, G O, Sundlöv, A, Svensson, J B, Garresori, H, Kersten, C, Hofsli, E, Detlefsen, S, Krogh, M, Sorbye, H & Knappskog, S 2022, ' The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms ', Endocrine-Related Cancer, vol. 29, no. 1, pp. 1-14 . https://doi.org/10.1530/ERC-21-0152
Endocrine-Related Cancer
Venizelos, A, Elvebakken, H, Perren, A, Nikolaienko, O, Deng, W, Lothe, I M B, Couvelard, A, Hjortland, G O, Sundlöv, A, Svensson, J B, Garresori, H, Kersten, C, Hofsli, E, Detlefsen, S, Krogh, M, Sorbye, H & Knappskog, S 2022, ' The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms ', Endocrine-Related Cancer, vol. 29, no. 1, pp. 1-14 . https://doi.org/10.1530/ERC-21-0152
High-grade (HG) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are rare but have a very poor prognosis and represent a severely understudied class of tumours. Molecular data for HG GEP-NEN are limited, and treatment strategies for the ca
Publikováno v:
Journal of Neuroendocrinology. 34
For patients with gastroenteropancreatic neuroendocrine tumours (GEP-NET), health-related quality of life (HRQoL) is important. Meanwhile, whether tumour volume is associated with HRQoL is unknown. Hence, the aim of this study was to assess if total
Autor:
Anna Sundlöv, Daniel Roth, Carl Fredrik Warfvinge, Johan Gustafsson, Anna Åkesson, Jan Tennvall, Katarina Sjögreen Gleisner
Publikováno v:
J Nucl Med
Tumor dosimetry was performed for 177Lu-DOTA-TATE with the aims of better understanding i) the range and variation of the tumor absorbed doses (ADs), ii) how different dosimetric quantities evolve over the treatment cycles, and iii) whether this evol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0b9801d85ce5682d38e9ebac1ec5d7
https://europepmc.org/articles/PMC8978188/
https://europepmc.org/articles/PMC8978188/